000 01447 a2200421 4500
005 20250510214335.0
264 0 _c19760525
008 197605s 0 0 eng d
022 _a0042-6822
024 7 _a10.1016/0042-6822(76)90494-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHampar, B
245 0 0 _aCell cycle dependence for activation of Epstein-Barr virus by inhibitors of protein synthesis or medium deficient in arginine.
_h[electronic resource]
260 _bVirology
_cFeb 1976
300 _a660-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAntigens, Viral
650 0 4 _aArginine
_xmetabolism
650 0 4 _aCell Division
650 0 4 _aCell Line
650 0 4 _aCulture Media
650 0 4 _aCycloheximide
_xpharmacology
650 0 4 _aCytarabine
_xpharmacology
650 0 4 _aDNA, Neoplasm
_xbiosynthesis
650 0 4 _aDNA, Viral
_xbiosynthesis
650 0 4 _aHerpesvirus 4, Human
_xgrowth & development
650 0 4 _aHydroxyurea
_xpharmacology
650 0 4 _aNeoplasm Proteins
_xbiosynthesis
650 0 4 _aPuromycin
_xpharmacology
650 0 4 _aRNA, Neoplasm
_xbiosynthesis
650 0 4 _aVirus Replication
700 1 _aLenoir, G
700 1 _aNonoyama, M
700 1 _aDerger, J G
700 1 _aChang, S
773 0 _tVirology
_gvol. 69
_gno. 2
_gp. 660-8
856 4 0 _uhttps://doi.org/10.1016/0042-6822(76)90494-3
_zAvailable from publisher's website
999 _c173728
_d173728